KalVista Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 59.9M | 40.9M | 13.7M | 1.4M | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 4.0M | 3.4M | 1.2M | 590K | 15.9M | 0 | 0 | 0 |
| Gross Profit | 55.9M | 37.4M | 12.5M | 836K | -15.9M | 0 | 0 | 0 |
| R&D Expenses | 8.8M | 12.4M | 12.0M | 15.2M | 15.9M | 12.6M | 16.6M | 26.6M |
| Operating Expenses | 67.5M | 60.9M | 58.5M | 59.8M | 39.1M | 42.9M | 45.8M | 44.2M |
| Operating Income | -11.5M | -23.4M | -46.0M | -59.0M | -55.0M | -42.9M | -45.8M | -44.2M |
| Other Income / Gains | -959K | -45K | -1.3M | 1.1M | 1.9M | -1.3M | 3.5M | 3.8M |
| Net Income | -5.4M | -23.5M | -49.5M | -60.1M | -52.2M | -48.5M | -42.3M | -40.4M |
| EPS (Diluted) | -0.11 | -1.08 | -0.92 | -1.12 | -1.05 | -0.92 | -0.91 | -0.87 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.934 | 0.916 | 0.91 | 0.586 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 0 | 0 | 46.5M | 44.7M | 39.1M | 30.3M | 29.2M | 17.6M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 58.6M | 48.4M | 46.5M | 44.7M | 39.1M | 30.3M | 29.2M | 17.6M |
| Other Expenses | 0 | 0 | 0 | 0 | -15.9M | 0 | 0 | 0 |
| Cost And Expenses | 71.4M | 64.3M | 59.7M | 60.4M | 55.0M | 42.9M | 45.8M | 44.2M |
| Interest Income | 3.4M | 2.5M | 1.9M | 1.8M | 2.0M | 1.4M | 1.4M | 1.7M |
| Interest Expense | 8.6M | 5.6M | 4.8M | 3.5M | 2.9M | 2.8M | 0 | 0 |
| Depreciation And Amortization | 587K | 355K | 369K | 252K | 261K | 229K | 227K | 224K |
| Ebitda | -3.2M | -17.5M | -42.2M | -54.2M | -49.9M | -41.2M | -42.0M | -40.2M |
| Ebitdaratio | -0.054 | -0.429 | -3.082 | -37.984 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | -0.192 | -0.574 | -3.363 | -41.381 | 0 | 0 | 0 | 0 |
| Income Before Tax | -12.5M | -23.5M | -47.3M | -57.9M | -53.1M | -44.3M | -42.3M | -40.4M |
| Income Before Tax Ratio | -0.208 | -0.575 | -3.456 | -40.63 | 0 | 0 | 0 | 0 |
| Income Tax Expense | -7.1M | 0 | 2.2M | 2.2M | -855K | 4.2M | 0 | 0 |
| Net Income Ratio | -0.09 | -0.575 | -3.614 | -42.143 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.11 | -1.08 | -0.92 | -1.12 | -1.05 | -0.92 | -0.91 | -0.87 |
| Weighted Average Shs Out | 50.5M | 50.9M | 53.9M | 53.5M | 49.7M | 52.6M | 46.7M | 46.2M |
| Weighted Average Shs Out Dil | 50.5M | 50.9M | 53.9M | 53.5M | 49.7M | 52.6M | 46.7M | 46.2M |